Martins David, Tareen Naureen, Nicholas Susanne B, Jones Loretta, Norris Keith C
Charles R. Drew University of Medicine & Science, Los Angeles, CA 90059, USA.
Ethn Dis. 2004 Autumn;14(4):S2-38-41.
African Americans suffer from high rates of hypertension and hypertension-related complications. While racial/ethnic differences in blood pressure response to pharmacologic therapy have been described, most randomized hypertension trials with substantial enrollment of African Americans receiving standardized medical care do not support class-specific racial/ethnic differences in key clinical outcomes. Understanding health care systems and the socio-economic and demographic factors that impair access can enhance the ability of the provider to enlist and engage the patient for optimal blood pressure control and end organ protection.
非裔美国人高血压及高血压相关并发症的发病率很高。虽然已有研究描述了在药物治疗中血压反应的种族/族裔差异,但大多数纳入大量接受标准化医疗护理的非裔美国人的随机高血压试验并不支持在关键临床结局方面存在特定类别药物的种族/族裔差异。了解医疗保健系统以及影响就医机会的社会经济和人口因素,可以提高医疗服务提供者争取患者并促使其参与治疗以实现最佳血压控制和保护终末器官的能力。